These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

110 related articles for article (PubMed ID: 4018344)

  • 1. The cobra complement system: II. The membrane attack complex.
    Vogel CW; Müller-Eberhard HJ
    Dev Comp Immunol; 1985; 9(2):327-33. PubMed ID: 4018344
    [TBL] [Abstract][Full Text] [Related]  

  • 2. Molecular organization of C9 within the membrane attack complex of complement. Induction of circular C9 polymerization by the C5b-8 assembly.
    Podack ER; Tschoop J; Müller-Eberhard HJ
    J Exp Med; 1982 Jul; 156(1):268-82. PubMed ID: 6177822
    [TBL] [Abstract][Full Text] [Related]  

  • 3. The cobra complement system: I. The alternative pathway of activation.
    Vogel CW; Müller-Eberhard HJ
    Dev Comp Immunol; 1985; 9(2):311-25. PubMed ID: 3894085
    [TBL] [Abstract][Full Text] [Related]  

  • 4. The membrane attack complex of complement: C5b-8 complex as accelerator of C9 polymerization.
    Tschopp J; Podack ER; Müller-Eberhard HJ
    J Immunol; 1985 Jan; 134(1):495-9. PubMed ID: 3964819
    [TBL] [Abstract][Full Text] [Related]  

  • 5. Molecular composition of the terminal membrane and fluid-phase C5b-9 complexes of rabbit complement. Absence of disulphide-bonded C9 dimers in the membrane complex.
    Bhakdi S; Tranum-Jensen J
    Biochem J; 1983 Mar; 209(3):753-61. PubMed ID: 6870789
    [TBL] [Abstract][Full Text] [Related]  

  • 6. Measurement of the ratio of the eighth and ninth components of human complement on complement-lysed membranes.
    Stewart JL; Monahan JB; Brickner A; Sodetz JM
    Biochemistry; 1984 Aug; 23(18):4016-22. PubMed ID: 6487588
    [TBL] [Abstract][Full Text] [Related]  

  • 7. Enhanced reactive lysis of paroxysmal nocturnal hemoglobinuria erythrocytes. Studies on C9 binding and incorporation into high molecular weight complexes.
    Rosenfeld SI; Jenkins DE; Leddy JP
    J Exp Med; 1986 Oct; 164(4):981-97. PubMed ID: 3760783
    [TBL] [Abstract][Full Text] [Related]  

  • 8. On the cause and nature of C9-related heterogeneity of terminal complement complexes generated on target erythrocytes through the action of whole serum.
    Bhakdi S; Tranum-Jensen J
    J Immunol; 1984 Sep; 133(3):1453-63. PubMed ID: 6747293
    [TBL] [Abstract][Full Text] [Related]  

  • 9. C5b-9 assembly: average binding of one C9 molecule to C5b-8 without poly-C9 formation generates a stable transmembrane pore.
    Bhakdi S; Tranum-Jensen J
    J Immunol; 1986 Apr; 136(8):2999-3005. PubMed ID: 3958488
    [TBL] [Abstract][Full Text] [Related]  

  • 10. The C8-binding protein of human erythrocytes: interaction with the components of the complement-attack phase.
    Schönermark S; Filsinger S; Berger B; Hänsch GM
    Immunology; 1988 Apr; 63(4):585-90. PubMed ID: 3366469
    [TBL] [Abstract][Full Text] [Related]  

  • 11. Formation of ion-conducting channels by the membrane attack complex proteins of complement.
    Shiver JW; Dankert JR; Esser AF
    Biophys J; 1991 Oct; 60(4):761-9. PubMed ID: 1720679
    [TBL] [Abstract][Full Text] [Related]  

  • 12. Human protectin (CD59), an 18,000-20,000 MW complement lysis restricting factor, inhibits C5b-8 catalysed insertion of C9 into lipid bilayers.
    Meri S; Morgan BP; Davies A; Daniels RH; Olavesen MG; Waldmann H; Lachmann PJ
    Immunology; 1990 Sep; 71(1):1-9. PubMed ID: 1698710
    [TBL] [Abstract][Full Text] [Related]  

  • 13. Deposition of terminal C5b-9 complement complexes on erythrocytes and leukocytes during cardiopulmonary bypass.
    Salama A; Hugo F; Heinrich D; Höge R; Müller R; Kiefel V; Mueller-Eckhardt C; Bhakdi S
    N Engl J Med; 1988 Feb; 318(7):408-14. PubMed ID: 3340119
    [TBL] [Abstract][Full Text] [Related]  

  • 14. Target deletion of complement component 9 attenuates antibody-mediated hemolysis and lipopolysaccharide (LPS)-induced acute shock in mice.
    Fu X; Ju J; Lin Z; Xiao W; Li X; Zhuang B; Zhang T; Ma X; Li X; Ma C; Su W; Wang Y; Qin X; Liang S
    Sci Rep; 2016 Jul; 6():30239. PubMed ID: 27444648
    [TBL] [Abstract][Full Text] [Related]  

  • 15. Species-restricted target cell lysis by human complement: complement-lysed erythrocytes from heterologous and homologous species differ in their ratio of bound to inserted C9.
    Hu VW; Shin ML
    J Immunol; 1984 Oct; 133(4):2133-7. PubMed ID: 6470486
    [TBL] [Abstract][Full Text] [Related]  

  • 16. Molecular mechanisms of cytotoxicity: comparison of complement and killer lymphocytes.
    Müller-Eberhard HJ; Zalman LS; Chiu FJ; Jung G; Martin DE
    J Rheumatol Suppl; 1987 Jun; 14 Suppl 13():28-34. PubMed ID: 3612651
    [TBL] [Abstract][Full Text] [Related]  

  • 17. Characterization of the enhanced susceptibility of paroxysmal nocturnal hemoglobinuria erythrocytes to complement-mediated hemolysis initiated by cobra venom factor.
    Parker CJ; Stone OL; Bernshaw NJ
    J Immunol; 1989 Jan; 142(1):208-16. PubMed ID: 2909615
    [TBL] [Abstract][Full Text] [Related]  

  • 18. Complement lysis of U937, a nucleated mammalian cell line in the absence of C9: effect of C9 on C5b-8 mediated cell lysis.
    Morgan BP; Imagawa DK; Dankert JR; Ramm LE
    J Immunol; 1986 May; 136(9):3402-6. PubMed ID: 3514758
    [TBL] [Abstract][Full Text] [Related]  

  • 19. The structural events associated with the attachment of complement components to cell membranes in reactive lysis.
    Dourmashkin RR
    Immunology; 1978 Aug; 35(2):205-12. PubMed ID: 750370
    [TBL] [Abstract][Full Text] [Related]  

  • 20. Suppression of the anti-erythrocyte immune response in mice by the C5b--9 complex of complement.
    Horn W; Opferkuch W; Podack ER
    Immunology; 1981 Jun; 43(2):303-9. PubMed ID: 7019052
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 6.